Your browser doesn't support javascript.
loading
Reductions in liver enzymes are associated with anti-hyperglycaemic and anti-obesity effects of tofogliflozin in people with type 2 diabetes: Post-hoc analyses.
Takamura, Toshinari; Kaku, Kohei; Yoshida, Akihiro; Kusakabe, Hiromi; Nakamura, Hiroyuki; Suganami, Hideki.
Afiliação
  • Takamura T; Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
  • Kaku K; Department of Internal Medicine, Kawasaki Medical School, Kurashiki, Japan.
  • Yoshida A; Kowa Co., Ltd., Tokyo, Japan.
  • Kusakabe H; Kowa Co., Ltd., Tokyo, Japan.
  • Nakamura H; Department of Hygiene and Public Health, , Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
  • Suganami H; Clinical Data Science Department, Kowa Co., Ltd., Tokyo, Japan.
Endocrinol Diabetes Metab ; 7(1): e461, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37986236
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos / Hiperglicemia Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos / Hiperglicemia Idioma: En Ano de publicação: 2024 Tipo de documento: Article